JP Patent
JP7670945B2 — 老眼、散瞳、および他の眼障害の治療のための方法および組成物
Assigned to Opus Genetics Inc · Expires 2025-05-01 · 1y expired
What this patent protects
Patent listed against phentolamine-mesylate.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.